Frédéric Perros Selected Research

Sirtuin 1

1/2018

Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation: role in pulmonary arterial hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frédéric Perros Research Topics

Disease

24	Pulmonary Hypertension 05/2024 - 07/2011
24	Pulmonary Arterial Hypertension 05/2024 - 02/2005
10	Hypoxia (Hypoxemia) 01/2022 - 01/2014
10	Familial Primary Pulmonary Hypertension 01/2020 - 11/2007
7	Vascular Remodeling 01/2024 - 11/2007
7	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 12/2022 - 09/2015
6	Inflammation (Inflammations) 12/2021 - 09/2011
4	Right Ventricular Hypertrophy 01/2023 - 01/2013
3	Vascular Diseases (Vascular Disease) 04/2024 - 11/2016
3	Cystic Fibrosis (Mucoviscidosis) 12/2022 - 01/2014
3	Heart Failure 07/2021 - 05/2012
3	Hypertrophy 02/2021 - 06/2014
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023 - 12/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2022 - 01/2014
2	Fibrosis (Cirrhosis) 11/2021 - 06/2014
2	Rare Diseases (Rare Disease) 01/2016 - 09/2015
2	Autoimmune Diseases (Autoimmune Disease) 06/2013 - 10/2012
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2012 - 06/2007
1	Dyspnea (Shortness of Breath) 05/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2024
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 11/2023
1	Thrombosis (Thrombus) 01/2023
1	Heart Diseases (Heart Disease) 01/2022
1	Pulmonary Embolism 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2021
1	Drug-Related Side Effects and Adverse Reactions 08/2021
1	Anemia 07/2021
1	Iron Deficiencies 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Genomic Instability 07/2019
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2019
1	Neoplasms (Cancer) 01/2016
1	Cardiomegaly (Heart Hypertrophy) 01/2016
1	Pneumonia (Pneumonitis) 01/2016

Drug/Important Bio-Agent (IBA)

13	MonocrotalineIBA 11/2021 - 09/2011
4	Transcription Factors (Transcription Factor)IBA 01/2023 - 11/2016
3	Semaxinib (SU5416)IBA 01/2023 - 10/2020
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 02/2005
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2021 - 09/2015
3	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 10/2020 - 11/2016
3	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 01/2018 - 10/2015
2	CollagenIBA 04/2024 - 12/2021
2	CytokinesIBA 12/2022 - 11/2007
2	SolventsIBA 12/2022 - 12/2015
2	Messenger RNA (mRNA)IBA 11/2021 - 01/2014
2	IronIBA 07/2021 - 01/2021
2	LigandsIBA 02/2021 - 11/2007
2	Carbon MonoxideIBA 01/2021 - 01/2020
2	Serotonin (5 Hydroxytryptamine)IBA 10/2020 - 02/2005
2	DNA (Deoxyribonucleic Acid)IBA 07/2019 - 12/2016
2	potassium channel subfamily K member 3IBA 01/2019 - 04/2016
2	Phosphotransferases (Kinase)IBA 01/2018 - 10/2012
2	Interleukin-6 (Interleukin 6)IBA 08/2014 - 06/2014
2	AutoantibodiesIBA 06/2013 - 02/2012
1	carfilzomibIBA 05/2024
1	Bortezomib (Velcade)FDA Link 05/2024
1	Proteasome InhibitorsIBA 05/2024
1	VimentinIBA 01/2024
1	Apolipoproteins B (ApoB)IBA 11/2023
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2022
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2022
1	Dobutamine FDA LinkGeneric 01/2022
1	jugloneIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2021
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2021
1	Leflunomide (Arava)FDA LinkGeneric 08/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	EnbucrilateIBA 11/2020
1	Vitamin D FDA LinkGeneric 10/2020
1	PotassiumIBA 10/2020
1	Trichloroethylene (Trichloroethene)IBA 10/2020
1	SurvivinIBA 10/2020
1	cadherin 5IBA 10/2020
1	15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA 01/2020
1	LipidsIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2020
1	hemoglobin DIBA 01/2020
1	AcidsIBA 01/2020
1	CholesterolIBA 01/2020
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2018
1	Sirtuin 1IBA 01/2018
1	N-Methylaspartate (NMDA)IBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 01/2018
1	CalciumIBA 11/2016
1	hydralazine 4-anisaldehyde hydrazoneIBA 11/2016
1	ProteomeIBA 10/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Potassium Channels (Potassium Channel)IBA 10/2015
1	Metoprolol (Toprol-XL)FDA LinkGeneric 02/2015
1	Nebivolol FDA Link 02/2015
1	Alkylating AgentsIBA 02/2015

Therapy/Procedure

9	Therapeutics 12/2021 - 06/2007
3	Drug Therapy (Chemotherapy) 12/2022 - 02/2015
2	Transplantation 10/2012 - 06/2012
1	Hematopoietic Stem Cell Transplantation 01/2019